Levels of lipoprotein (a) in pulmonary arterial hypertension

Cardiology in the Young

Volumn 11, Issue 1, 2001, Pages 25-29

  Santos, Raul D ^a   Foronda, Antonio ^a   Ramires, José A F ^a   Maranhão, Raul C ^a,b,c  

^a Heart Institute (InCor)   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c NONE   (Brazil)

Author keywords

Congenital cardiac malformations; Lipoprotein (a); Pulmonary hypertension

Indexed keywords

LIPOPROTEIN A;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CASE CONTROL STUDY; CHILD; CONGENITAL HEART MALFORMATION; EISENMENGER COMPLEX; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PRESCHOOL CHILD; PULMONARY HYPERTENSION;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; EISENMENGER COMPLEX; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; HYPERTENSION, PULMONARY; LIPOPROTEIN(A); MALE; MIDDLE AGED;

EID: 0035229098     PISSN: 10479511     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1047951100012385     Document Type: Article

References (22)

1. Utterrman G. Lipoprotein(a). In: The metabolic and molecular bases of inherited disease. Scriver CL, Beaudet AL, Williams SS, Valle D eds. New York Mc Graw-Hill, 1995:1887-1912.
2. Grainger DJ, Kirschenlohr HL, Metcalfe JC, Weissberg PL, Wade DP, Lawn RM. Proliferation of human muscle cells promoted by lipoprotein(a). Science 1993;260:1655-1658.
3. Gaw A, Hobbs HH. Molecular genetics of lipoprotein(a):New pieces to the puzzle. Curr Op Lipidol 1994;5:149-155.
4. Kostner GM, Avogaro P, Cazzolato G, Morth E, Bittolo-Bon G, Quina GB. Lipoprotein(a) Lp(a) and the risk for myocardial infarction. Atherosclerosis 1981;38:51-61.
5. Scott J. Thrombogenesis linked to atherogenesis at last? Nature 1989;341:22-23.
6. Maeda S, Abe A, Seishima M, Makino K, Noma A, Kawade M. Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis 1989;78:145-150.
7. Oshima S, Uchida K, Yasu T, Uno K, Nonogi H, Haze K. Transient increase of plasma lipoprotein(a) in patients with unstable angina pectoris. Arterioscler and Thromb 1991;11:1772-1777.
8. Rich S, Brundage BH. Pulmonary hypertension: a cellular basis for understanding the pathophysiology and treatment. J Amer Coll Cardiol 1989;14:545-550.
9. Chaouat A, Weitzenblum E, Higenbottam T. The role of thrombosis in severe pulmonary hypertension. Eur Respir J 1996;9:356-363.
10. Voelkel NF, Tuder RM. Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension. Eur Respir J 1995;8:2129-2138
11. Greenberg HE, Scharf FM. Pulmonary hypertension: pathophysiology and clinical disorders. In: Baum GL, Wolinsky E; eds. Textbook of Pulmonary Diseases. Boston : Little, Brown and Co;1994:1285-1304.
12. Rich S, Braunwald E, Grossman W. Pulmonary Hypertension In Heart Disease. Braunwald E ed. Philadelphia, W.B. Saunders Co; 1997;780-806.
13. Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Koerner SK. Primary Pulmonary Hypertension. A National prospective study Ann Intern Med 1987;107:216-223.
14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of preparative ultracentrifuge. Clin Chem 1972;18: 499-502.
15. Tuder RM, groves B, Badesch DB, Voelkel NF. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension, Amer J Pathol 1994;144:275-85.
16. Borba EF, Santos RD, Bonfa E, Vinagre CG, Pileggi FJ, Cossermelli W, Maranhao RC. Lipoprotein(a) levels in systemic lupus erithematosus. J Rheumatol 1994;21:220-3.
17. Takami S, Kubo M, Yamashita S, Kameda-Takemura K, Kawasaki T, Kanbayashi J, Nakamura Y, Yokoi Y, Ohnishi K, Matsuzawa Y. High levels of serum lipoprotein(a) in patients with ischemic heart disease with normal coronary angiogram and thromboangiitis obliterans. Atherosclerosis 1995;112:253-60.
18. Wade DP, Clarke JG, Lindahl GE, Liu AC, Zysow BR, Meer K, Schwartz K, Lawn RM. 5' Control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family. Proc Natl Acad Sci USA 1993;90:1369-73.
19. Grainger DJ, Kemp PR, Metcalfe JC, Liu AC, Lawn RM, Williams NR, Grace AA, Schofield PM, Chauhan A. The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis. Nat Med 1995;1:74-79.
20. Kinlay S, Dobson AJ, Heller RF, McElduff P, Alexander H, Dickeson J. Risk of primary and recurrent acute myocardial infarction from lipoprotein(a) in men and women. J Amer Coll Cardiol 1996;28:870-5.
21. Galie N, Grigioni F, Uguccioni L, Cervi V, Di Luzio S, Serafini F, Catanzariti P, Callegari G, Fracchia C, Branzi A. Magnani B. Increased levels of α-TNF in patients with primary pulmonary hypertension. Eur Heart J 1997;18 supl:528.
22. Braunwald E, Colucci WS, Grossman W Clinical Aspects of heart failure: high-output, heart failure, pulmonary edema. In Heart Disease. Braunwald E ed. Philadelphia, WB. Saunders Co; 1997;445-470.